Polymorphism of COMT Val158Met is associated with inhalant use and dependence: a Thai substance dependence treatment cohort

1. Wu LT, Ringwalt CL. Inhalant use and disorders among adults in the United States. Drug Alcohol Depend. 2006; 85:1-11.10.1016/j.drugalcdep.2006.01.017Open DOISearch in Google Scholar

2. Yucel M, Takagi M, Walterfang M, Lubman DI. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev. 2008; 32:910-26.10.1016/j.neubiorev.2008.01.006Open DOISearch in Google Scholar

3. Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatric services. 1998; 49:812-6.10.1176/ps.49.6.812Open DOISearch in Google Scholar

4. Okudaira K, Yabana T, Takahashi H, Iizuka H, Nakajima K, Saito A. Inhalant abusers and psychiatric symptoms. Seishin Shinkeigaku Zasshi. 1996; 98: 203-12.Search in Google Scholar

5. Wada K, Nakayama K, Koishikawa H, Katayama M, Hirai S, Yabana T, et al. Symptomatological structure of volatile solvent-induced psychosis: is “solvent psychosis” a discernible syndrome. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2005; 40:471-84.Search in Google Scholar

6. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. American family physician. 2003; 68: 869-74.Search in Google Scholar

7. Bale AS, Tu Y, Carpenter-Hyland EP, Chandler LJ, Woodward JJ. Alterations in glutamatergic and GABAergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience. 2005; 130:197-206.10.1016/j.neuroscience.2004.08.040Open DOISearch in Google Scholar

8. Medina-Mora ME, Real T. Epidemiology of inhalant use. Curr Opin Psychiatry. 2008; 21:247-51.10.1097/YCO.0b013e3282fc9875Open DOISearch in Google Scholar

9. Konghom S, Verachai V, Srisurapanont M, Suwanmajo S, Ranuwattananon A, Kimsongneun N, et al. Treatment for inhalant dependence and abuse (Review). The Cochrane Library. 2010.10.1002/14651858.CD007537.pub2Search in Google Scholar

10. Ridenour TA. Inhalants: not to be taken lightly anymore. Curr Opin Psychiatry. 2005; 18:243-7.10.1097/01.yco.0000165593.52811.cdOpen DOISearch in Google Scholar

11. Winqvist R, Lundstrom K, Salminen M, Laatikainen M, Ulmanen I. The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet. 1992; 59:253-7.10.1159/000133262Open DOISearch in Google Scholar

12. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardiofacial syndrome. Am J Med Genet. 1996; 67:468-72.10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-GSearch in Google Scholar

13. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry. 2004; 9:151-60.10.1038/sj.mp.4001386Open DOISearch in Google Scholar

14. Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem. 1958; 233:702-5.10.1016/S0021-9258(18)64731-3Search in Google Scholar

15. Ucok A, Ozturk M, Duman Z, Saruhan-Direskeneli G. COMT Val158Met polymorphism is related with interpersonal problem solving in schizophrenia. European Psychiatry. 2010; 25: 320-2.10.1016/j.eurpsy.2010.01.01220570494Open DOISearch in Google Scholar

16. Benedetti F, Dallaspezia S, Colombo C, Lorenzi C, Pirovano A, Smeraldi E. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder. Journal of Affective Disorders. 2010; 125: 341-4.10.1016/j.jad.2010.01.00520122740Search in Google Scholar

17. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology. 2008; 33:3078-84.10.1038/npp.2008.126258321418704099Open DOISearch in Google Scholar

18. Administrative Committee on Substance Abuse Academic Network (ACSAN): National Household Survey on Substance Abuse 2007. Edited by Bangkok Office of the Narcotics Control Board; 2007.Search in Google Scholar

19. Malison RT, Kalayasiri R, Sanichwankul K, Sughondhabirom A, Mutirangura A, Pittman B, et al. Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). Addictive Behaviors. 2011; 36:156-60.10.1016/j.addbeh.2010.08.031298166220888699Open DOISearch in Google Scholar

20. Kalayasiri R, Mutirangura A, Verachai V, Gelernter J, Malison RT. Risk factors for methamphetamineinduced paranoia and latency of symptom onset in a Thai drug treatment cohort. Asian Biomed. 2009; 3: 635-43.Search in Google Scholar

21. Pierucci-Lagha A, Gelernter J, Feinn R, Cubells JF, Pearson D, Pollastri A, et al. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend. 2005; 80:303-12.10.1016/j.drugalcdep.2005.04.00515896927Open DOISearch in Google Scholar

22. Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry. 2004; 43: 1206-14.10.1097/01.chi.0000134491.42807.a3128312115381887Open DOISearch in Google Scholar

23. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings. Bethesda, MD: National Institute on Drug Abuse. 2009:14-5.10.1037/e560352009-001Search in Google Scholar

24. Riegel AC, Zapata A, Shippenberg TS, French ED. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology. 2007; 32:1558-69.10.1038/sj.npp.130127317213847Open DOISearch in Google Scholar

25. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology. 2004; 47:227-41.10.1016/j.neuropharm.2004.06.03215464140Open DOISearch in Google Scholar

26. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007; 64:1575-9.10.1001/archneur.64.11.157517998440Open DOISearch in Google Scholar

27. Klanker M. Dopamine/Serotonin interactions in reward-related behavior: Focus on the Iowa Gambling Task: Utrecht University. 2008.Search in Google Scholar

28. Axelrod J. The metabolism of catecholamines in vivo and in vitro. Pharmacol Rev. 1959; 11:402-8.Search in Google Scholar

29. Starr JM, Fox H, Harris SE, Deary IJ, Whalley LJ. COMT genotype and cognitive ability: a longitudinal aging study. Neurosci Lett. 2007; 421:57-61.10.1016/j.neulet.2007.05.02317548151Open DOISearch in Google Scholar

30. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001; 98:6917-22.10.1073/pnas.1111345983445311381111Search in Google Scholar

31. Wu LT, Howard MO, Pilowsky DJ. Substance use disorders among inhalant users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addict Behav. 2008; 33:968-73.10.1016/j.addbeh.2008.02.019242284818403132Open DOISearch in Google Scholar

32. Kelder SH, Murray NG, Orpinas P, Prokhorov A, McReynolds L, Zhang Q, et al. Depression and substance use in minority middle-school students. Am J Public Health. 2001; 91:761-6.10.2105/AJPH.91.5.761144666811344884Search in Google Scholar

33. Kubik MY, Lytle LA, Birnbaum AS, Murray DM, Perry CL. Prevalence and correlates of depressive symptoms in young adolescents. Am J Health Behav. 2003; 27:546-53. 10.5993/AJHB.27.5.614521250Open DOISearch in Google Scholar